Creating personalised, compliant content is becoming increasingly important for life science companies as HCPs demand more from their digital content.
Pharma companies created 3.5 times more digital content than print in 2020, driven by the growing prevalence of digital channels during the early stages of the Covid-19 pandemic. Yet, two years on, marketers still face mounting pressure to accelerate production and deliver greater volumes of content across multiple channels, often without the support of additional resources.
While marketing technology allows for personalised customer experiences, ensuring that the content is relevant and valuable to the user remains an essential task. As such, it is crucial that marketers establish the right content and partnership model early on to effectively develop, approve, and deliver compliant assets across a variety of channels, ranging from creative designs and copy to claims and taxonomies.
In a digital environment where content is often reused, repurposed, and reapproved for different uses, channels, and recipients, managing and tracking content at scale can be a challenge, particularly for regional teams.
To help life science executives navigate the changing demands of digital content and get the most out of their relationships with agencies, Veeva has published a new ebook in collaboration with the Agency Opinion Leader Forum, Getting Ready for Modular Content: An Agency Perspective, looking at ways that a modular approach to content provides a flexible foundation for producing relevant commercial content faster and at scale.
There is no one-size-fits-all solution when it comes to developing modular content, and agencies need to partner with the right teams to re-think content creation. With modular content, agencies can test, learn, and optimise messages. Armed with this combination of an upfront strategy and purpose-built software, marketers can instead focus on delivering high-value content to meet demands.
In a new ebook, Veeva outlines core ways that adopting a modular approach to content can help pharma teams identify the best messages, designs, and channels to ensure that quality content reaches the right people at the right time.
The publication provides:
- Clear guidelines for how agencies can help you create a foundation for modular content
- Ways to accelerate content creation and medical, legal, and regulatory approval
- Guidance for creating and maintaining compliance
- A roadmap for achieving adoption across channels
Download the whitepaper here: https://go.veeva.com/eu/modular-content-agency-perspective
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,100 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.
This post was originally published on Source Link